These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1986975)

  • 1. Endometrial antibodies versus CA-125 for the detection of endometriosis.
    Wild RA; Hirisave V; Bianco A; Podczaski ES; Demers LM
    Fertil Steril; 1991 Jan; 55(1):90-4. PubMed ID: 1986975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the source of elevated serum levels of CA 125 in patients with endometriosis?
    Fedele L; Arcaini L; Baglioni A; Bianchi S; Menard S
    Eur J Obstet Gynecol Reprod Biol; 1989 Dec; 33(3):247-52. PubMed ID: 2689251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies associated with endometriosis: can their detection predict presence of the disease?
    Wild RA; Hirisave V; Podczaski ES; Coulam C; Shivers CA; Satyaswaroop PG
    Obstet Gynecol; 1991 Jun; 77(6):927-31. PubMed ID: 2030870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An endometrial antibody assay in the clinical diagnosis and management of endometriosis.
    Chihal HJ; Mathur S; Holtz GL; Williamson HO
    Fertil Steril; 1986 Sep; 46(3):408-11. PubMed ID: 3743793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiendometrial antibodies in patients with endometriosis.
    Wild RA; Shivers CA
    Am J Reprod Immunol Microbiol; 1985 Jul; 8(3):84-6. PubMed ID: 3895994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity to endometrium and ovary in endometriosis.
    Mathur S; Peress MR; Williamson HO; Youmans CD; Maney SA; Garvin AJ; Rust PF; Fudenberg HH
    Clin Exp Immunol; 1982 Nov; 50(2):259-66. PubMed ID: 6759000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of CA125 (carbon hydrate tumor-associated antigen) and endometrial antibodies for the detections of endometriosis].
    Yang F; Fang AH; Gu RF
    Zhonghua Fu Chan Ke Za Zhi; 1994 Mar; 29(3):147-9, 189. PubMed ID: 8082430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial immunofluorescence associated with endometriosis and pelvic inflammatory disease.
    Kreiner D; Fromowitz FB; Richardson DA; Kenigsberg D
    Fertil Steril; 1986 Aug; 46(2):243-6. PubMed ID: 3525236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between uterine myoma and endometriosis using CA 125 as a new tumor marker of ovarian carcinoma.
    Takahashi K; Kijima S; Yoshino K; Shibukawa T; Murao F; Kitao M
    Asia Oceania J Obstet Gynaecol; 1986 Mar; 12(1):99-103. PubMed ID: 3459417
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
    Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.
    Nagata H; Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Kitao M
    Gynecol Obstet Invest; 1989; 28(3):165-8. PubMed ID: 2680806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-endometrial and anti-endothelial auto-antibodies in women with endometriosis.
    Fernández-Shaw S; Hicks BR; Yudkin PL; Kennedy S; Barlow DH; Starkey PM
    Hum Reprod; 1993 Feb; 8(2):310-5. PubMed ID: 8473439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial localization of antiendometrial antibodies associated with endometriosis.
    Wild RA; Satyaswaroop PG; Shivers AC
    Am J Reprod Immunol Microbiol; 1987 Feb; 13(2):62-5. PubMed ID: 2438953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA 125 in serum, peritoneal fluid, active lesions, and endometrium of patients with endometriosis.
    Fedele L; Vercellini P; Arcaini L; da Dalt MG; Candiani GB
    Am J Obstet Gynecol; 1988 Jan; 158(1):166-70. PubMed ID: 3422132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CA-125 levels in women with endometriosis.
    Grover S; Koh H
    Aust N Z J Obstet Gynaecol; 1990 Aug; 30(3):279-80. PubMed ID: 2256870
    [No Abstract]   [Full Text] [Related]  

  • 16. Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6-month therapy.
    Marana R; Muzii L; Muscatello P; Lanzone A; Caruso A; Dell'Acqua S; Mancuso S
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1016-9. PubMed ID: 2147564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA-125 levels in the diagnosis and management of endometriosis.
    Lanzone A; Marana R; Muscatello R; Fulghesu AM; Dell'Acqua S; Caruso A; Mancuso S
    J Reprod Med; 1991 Aug; 36(8):603-7. PubMed ID: 1834843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CA 125 as a marker for patients with external endometriosis.
    Takahashi K; Kijima S; Yoshino K; Shibukawa T; Kitao M
    Int J Fertil; 1989; 34(2):143-8. PubMed ID: 2565317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of CA-125 tumor marker in endometrial carcinoma.
    Kukura V; Zaninović I; Hrdina B
    Gynecol Oncol; 1990 Jun; 37(3):388-9. PubMed ID: 2351323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological aspects of endometriosis].
    Kuhn U
    Gynakologe; 1990 Jun; 23(3):135-9. PubMed ID: 2201598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.